Filing Details
- Accession Number:
- 0000950170-25-026609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-25 16:03:08
- Reporting Period:
- 2025-02-24
- Filing Date:
- 2025-02-25
- Accepted Time:
- 2025-02-25 16:03:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1971543 | Mural Oncology Plc | MURA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1901477 | L Vicki Goodman | C/O Mural Oncology Plc 10 Earlsfort Terrace Dublin 2 L2 D02 T380 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2025-02-24 | 13,186 | $3.89 | 54,763 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold by the Reporting Person pursuant to a Rule 10b5-1 trading arrangement that was entered into by the Reporting Person on October 24, 2024.
- Includes 54,763 unvested restricted stock units.